Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

884 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritis.
Umekita K, Hidaka T, Ueno S, Takajo I, Kai Y, Nagatomo Y, Sawaguchi A, Suganuma T, Okayama A. Umekita K, et al. Among authors: hidaka t. Mod Rheumatol. 2009;19(3):265-72. doi: 10.1007/s10165-009-0164-2. Epub 2009 Apr 1. Mod Rheumatol. 2009. PMID: 19337689
A multicenter study of leukocytapheresis in rheumatoid arthritis.
Ueki Y, Sagawa A, Tanimura K, Yamada A, Yamamoto K, Tsuda H, Tohma S, Suzuki K, Tominaga M, Kawabe Y, Mine M, Honda S, Tsukano M, Nakamura T, Hidaka T, Eguchi K. Ueki Y, et al. Among authors: hidaka t. Clin Exp Rheumatol. 2007 Nov-Dec;25(6):810-6. Clin Exp Rheumatol. 2007. PMID: 18173913
Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.
Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Takeuchi T; Japan Biological Agent Study Integrated Consortium. Kameda H, et al. Among authors: hidaka t. Mod Rheumatol. 2010 Dec;20(6):531-8. doi: 10.1007/s10165-010-0324-4. Epub 2010 Jun 24. Mod Rheumatol. 2010. PMID: 20574649 Clinical Trial.
Leukocytapheresis in rheumatoid arthritis.
Hidaka T, Hashiba Y, Kubo K, Kai Y, Maeda K. Hidaka T, et al. Transfus Apher Sci. 2017 Oct;56(5):698-702. doi: 10.1016/j.transci.2017.08.017. Epub 2017 Aug 30. Transfus Apher Sci. 2017. PMID: 28918917 Review.
Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.
Suzuki T, Fukui S, Umekita K, Miyamoto J, Umeda M, Nishino A, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Fujikawa K, Aramaki T, Mizokami A, Matsuoka N, Ueki Y, Eguchi K, Sato S, Hidaka T, Origuchi T, Okayama A, Kawakami A, Nakamura H. Suzuki T, et al. Among authors: hidaka t. Arthritis Rheumatol. 2018 Jul;70(7):1014-1021. doi: 10.1002/art.40461. Epub 2018 May 25. Arthritis Rheumatol. 2018. PMID: 29471588
The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study.
Umekita K, Hashiba Y, Kariya Y, Kubo K, Miyauchi S, Aizawa A, Umeki K, Nomura H, Kawaguchi T, Matsuda M, Takajo I, Hidaka T, Okayama A. Umekita K, et al. Among authors: hidaka t. Mod Rheumatol. 2019 Sep;29(5):795-801. doi: 10.1080/14397595.2018.1519890. Epub 2018 Oct 25. Mod Rheumatol. 2019. PMID: 30246572
884 results